India presently represents 3-4% of global biosimilar production, second to China and aims to increase it significantly. With ...

Few biologics in the US have multiple biosimilar competitors, but originator biologics respond quickly to competition by ...

Finally, the number of opportunities in the biosimilars space is very high — there are more than 300 biologics in the market, ...

The European Medicines Agency (EMA) could table proposals next year to relax requirements around the need for comparative ...

Joshua Cohen is a Boston-based writer who covers health policy. Biosimilars offer clinically effective treatment alternatives to branded reference drugs at a lower cost. These products are making ...

Biosimilars could improve access to biologic treatments and health care sustainability in Latin America, but their adoption ...

Over time, biosimilars are gaining traction in the US and becoming preferred products, explained James D. Chambers, PhD, of ...

Alvotech's biosimilars aim to lower healthcare costs amid rising drug prices and regulatory pressure against price hikes.

Global Biosimilars Week discussed issues in biosimilar adoption and called for reforms to streamline processes, foster ...

Humira is a self-injectable treatment used for a number of autoimmune disorders. Biosimilars reference originator biologics such as Humira. To gain approval by the the Food and Drug Administration ...

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have been given an average rating of “Moderate Buy” by ...

The Centers for Medicare & Medicaid Services is attempting to cover anti-obesity medications under Medicare Part D and ...